Anti-LRP5/6 antibodies and methods of use
Abstract:
The present invention provides anti-LRP5/6 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for treating diseases and disorders associated with Wnt pathway signaling.
Public/Granted literature
Information query
Patent Agency Ranking
0/0